BRIEF published on 07/09/2024 at 14:05, 1 year 4 months ago Hop On A Cure Makes Financial Contribution Toward ALS CURE Project Machine Learning Biomarkers Medical Research ALS Biometric Analysis
BRIEF published on 07/09/2024 at 14:05, 1 year 4 months ago Hop On A Cure apporte une contribution financière au projet ALS CURE Apprentissage Automatique Biomarqueurs Recherche Médicale SLA Analyse Biométrique
PRESS RELEASE published on 07/09/2024 at 14:00, 1 year 4 months ago Hop on a Cure Makes Financial Contribution Toward ALS CURE Project Hop On A Cure contributes to ALS CURE Project's 3ML Project, funding research on ALS biomarkers for early diagnosis and treatment. Impactful financial support from HOAC to accelerate ALS research Research Biomarkers ALS Hop On A Cure ALS CURE Project
BRIEF published on 04/24/2024 at 15:05, 1 year 7 months ago Hop on a Cure Donates $250,000 to Massachusetts General Hospital’s ALS Center Hop On A Cure ALS Research Massachusetts General Hospital Motor Neuron Regeneration Fundraising Activities
BRIEF published on 04/24/2024 at 15:05, 1 year 7 months ago Hop on a Cure fait un don de 250 000 $ au centre ALS du Massachusetts General Hospital Sautez Sur Un Remède Recherche Sur La SLA Hôpital Général Du Massachusetts Régénération Des Motoneurones Activités De Financement
PRESS RELEASE published on 04/24/2024 at 15:00, 1 year 7 months ago Hop on a Cure Makes Financial Contribution Toward Massachusetts General Hospital’s Sean M. Healey & AMG Center for ALS Hop On A Cure donates $250,000 to Massachusetts General Hospital for ALS research, supporting innovative therapies and young talent in the field Donation Hop On A Cure ALS Research Massachusetts General Hospital Innovative Therapies
Published on 12/05/2025 at 02:35, 4 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 12 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 51 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 17 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 27 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 32 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 27 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
